These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18504116)

  • 1. The promise of stem cell and regenerative therapies for multiple sclerosis.
    Payne N; Siatskas C; Bernard CC
    J Autoimmun; 2008 Nov; 31(3):288-94. PubMed ID: 18504116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis.
    Xiao J; Yang R; Biswas S; Qin X; Zhang M; Deng W
    Int J Mol Sci; 2015 Apr; 16(5):9283-302. PubMed ID: 25918935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prospect of stem cells as multi-faceted purveyors of immune modulation, repair and regeneration in multiple sclerosis.
    Payne N; Siatskas C; Barnard A; Bernard CC
    Curr Stem Cell Res Ther; 2011 Mar; 6(1):50-62. PubMed ID: 20955155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The remyelination Philosopher's Stone: stem and progenitor cell therapies for multiple sclerosis.
    Jadasz JJ; Aigner L; Rivera FJ; Küry P
    Cell Tissue Res; 2012 Jul; 349(1):331-47. PubMed ID: 22322424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regeneration and repair in multiple sclerosis: the role of cell transplantation.
    Pluchino S; Zanotti L; Brini E; Ferrari S; Martino G
    Neurosci Lett; 2009 Jun; 456(3):101-6. PubMed ID: 19429143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis: an altered immune response or an altered stress response?
    van Noort JM
    J Mol Med (Berl); 1996 Jun; 74(6):285-96. PubMed ID: 8862510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nogo in multiple sclerosis: growing roles of a growth inhibitor.
    Fontoura P; Steinman L
    J Neurol Sci; 2006 Jun; 245(1-2):201-10. PubMed ID: 16682057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nogo-A expresses on neural stem cell surface.
    Hou T; Shi Y; Cheng S; Yang X; Li L; Xiao C
    Int J Neurosci; 2010 Mar; 120(3):201-5. PubMed ID: 20374087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates.
    Pluchino S; Gritti A; Blezer E; Amadio S; Brambilla E; Borsellino G; Cossetti C; Del Carro U; Comi G; 't Hart B; Vescovi A; Martino G
    Ann Neurol; 2009 Sep; 66(3):343-54. PubMed ID: 19798728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Axonal Regeneration-related Molecules as Biomarkers for Multiple Sclerosis].
    Takahashi K; Tanaka F; Takei K
    Brain Nerve; 2016 Jan; 68(1):82-9. PubMed ID: 26764302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial precursor cell transplantation therapy for neurotrauma and multiple sclerosis.
    Kulbatski I; Mothe AJ; Parr AM; Kim H; Kang CE; Bozkurt G; Tator CH
    Prog Histochem Cytochem; 2008; 43(3):123-76. PubMed ID: 18706353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis.
    Gharibi T; Ahmadi M; Seyfizadeh N; Jadidi-Niaragh F; Yousefi M
    Cell Immunol; 2015 Feb; 293(2):113-21. PubMed ID: 25596473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin regulates immune cell adhesion and motility.
    Pool M; Niino M; Rambaldi I; Robson K; Bar-Or A; Fournier AE
    Exp Neurol; 2009 Jun; 217(2):371-7. PubMed ID: 19328785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble Nogo-A, an inhibitor of axonal regeneration, as a biomarker for multiple sclerosis.
    Jurewicz A; Matysiak M; Raine CS; Selmaj K
    Neurology; 2007 Jan; 68(4):283-7. PubMed ID: 17242333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures.
    Karussis D; Slavin S
    J Neurol Sci; 2004 Aug; 223(1):59-64. PubMed ID: 15261562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
    Mastronardi FG; Moscarello MA
    J Neurosci Res; 2005 May; 80(3):301-8. PubMed ID: 15704220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
    Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
    J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential DM20 mRNA expression distinguishes two distinct patterns of spontaneous recovery from murine autoimmune encephalomyelitis.
    Mathisen PM; Kawczak JA; Yu M; Johnson JM; Tuohy VK
    J Neurosci Res; 2001 Jun; 64(5):542-51. PubMed ID: 11391709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic use of stem cells for myelin repair in autoimmune demyelinating disorders.
    Pluchino S; Martino G
    J Neurol Sci; 2005 Jun; 233(1-2):117-9. PubMed ID: 15896808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure levels of anti-LINGO-1 Li81 antibody in the central nervous system and dose-efficacy relationships in rat spinal cord remyelination models after systemic administration.
    Pepinsky RB; Shao Z; Ji B; Wang Q; Meng G; Walus L; Lee X; Hu Y; Graff C; Garber E; Meier W; Mi S
    J Pharmacol Exp Ther; 2011 Nov; 339(2):519-29. PubMed ID: 21807883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.